fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Updates from SCORPIO-HR, a global phase III study of ensitrelvir for non-hospitalized participants with COVID-19 – Shionogi

Written by | 20 May 2024

Shionogi & Co., Ltd. announced that its pivotal, double-blind, randomized, placebo-controlled global Phase III study (SCORPIO-HR) did not meet its primary endpoint of a statistically significant reduction in… read more.

SARS-CoV-2 biochemistry explains important aspect of disease pathology

Written by | 9 May 2024

A known facet of coronavirus biochemistry helps to explain the pathological features of Covid-19 and may have implications for the management of long Covid and other conditions. Failure… read more.

How long COVID survivors are revolutionizing health care

Written by | 29 Mar 2024

To the world’s public health authorities, Covid-19 would be either a deadly disease for some or a simple respiratory illness for most, its symptoms clearing up in just… read more.

Vaccination before Covid-19 infection significantly reduces risk of long covid

Written by | 25 Nov 2023

Covid-19 vaccination prior to infection significantly reduces the risk of developing post-covid-condition (PCC), commonly known as long covid, researchers reported on Nov. 22, 2023 in The BMJ/British Medical… read more.

Staffing challenges and general time constraints may harm primary care teams’ ability to implement quality improvement efforts

Written by | 26 Sep 2023

Researchers aimed to identify factors leading primary care practice personnel to decline participation in quality improvement (QI) projects, and strategies to improve the feasibility and attractiveness of QI… read more.

Critical questions on the ivermectin meta-analysis

Written by | 12 Aug 2021

The methodological approach to the ivermectin meta-analysis provides further reassurance of the robustness of the findings. Mr Andrew Bryant and Dr Edmund Fordham describe some of the critical… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.